Enveric Biosciences Stock Price Prediction

ENVB Stock  USD 4.16  0.07  1.65%   
At the present time, the RSI of Enveric Biosciences' share price is approaching 40 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Enveric Biosciences, making its price go up or down.

Momentum 40

 Sell Extended

 
Oversold
 
Overbought
The successful prediction of Enveric Biosciences' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Enveric Biosciences, which may create opportunities for some arbitrage if properly timed.
Using Enveric Biosciences hype-based prediction, you can estimate the value of Enveric Biosciences from the perspective of Enveric Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Enveric Biosciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Enveric because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Enveric Biosciences after-hype prediction price

    
  USD 4.06  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Enveric Biosciences Basic Forecasting Models to cross-verify your projections.
For information on how to trade Enveric Stock refer to our How to Trade Enveric Stock guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Enveric Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.285.6019.36
Details
Naive
Forecast
LowNextHigh
0.094.7218.48
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
3.424.114.80
Details

Enveric Biosciences After-Hype Price Density Analysis

As far as predicting the price of Enveric Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Enveric Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Enveric Biosciences, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Enveric Biosciences Estimiated After-Hype Price Volatility

In the context of predicting Enveric Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Enveric Biosciences' historical news coverage. Enveric Biosciences' after-hype downside and upside margins for the prediction period are 0.20 and 17.82, respectively. We have considered Enveric Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
4.16
4.06
After-hype Price
17.82
Upside
Enveric Biosciences is dangerous at this time. Analysis and calculation of next after-hype price of Enveric Biosciences is based on 3 months time horizon.

Enveric Biosciences Stock Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Enveric Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Enveric Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Enveric Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.20 
13.79
 0.00  
  0.01 
0 Events / Month
1 Events / Month
In a few days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
4.16
4.06
3.10 
0.00  
Notes

Enveric Biosciences Hype Timeline

Enveric Biosciences is currently traded for 4.16. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.01. Enveric is anticipated to decline in value after the next headline, with the price expected to drop to 4.06. The average volatility of media hype impact on the company price is insignificant. The price decrease on the next news is expected to be -3.1%, whereas the daily expected return is currently at 0.2%. The volatility of related hype on Enveric Biosciences is about 38305.56%, with the expected price after the next announcement by competition of 4.17. The company has price-to-book (P/B) ratio of 1.25. Some equities with similar Price to Book (P/B) outperform the market in the long run. Enveric Biosciences recorded a loss per share of 119.64. The entity last dividend was issued on the 23rd of April 2008. The firm had 1:12 split on the 28th of October 2025. Given the investment horizon of 90 days the next anticipated press release will be in a few days.
Check out Enveric Biosciences Basic Forecasting Models to cross-verify your projections.
For information on how to trade Enveric Stock refer to our How to Trade Enveric Stock guide.

Enveric Biosciences Related Hype Analysis

Having access to credible news sources related to Enveric Biosciences' direct competition is more important than ever and may enhance your ability to predict Enveric Biosciences' future price movements. Getting to know how Enveric Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Enveric Biosciences may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
JSPRJasper Therapeutics 0.00 0 per month 0.00 (0.09) 7.73 (9.04) 31.75 
ONCOOnconetix 0.00 0 per month 0.00 (0.18) 9.09 (12.46) 36.81 
ZVSAZyVersa Therapeutics 0.36 4 per month 5.33  0.08  7.69 (10.53) 86.14 
INDPIndaptus Therapeutics 0.00 0 per month 0.00 (0.03) 13.58 (12.56) 51.64 
SPRCScisparc 0.00 0 per month 0.00 (0.37) 3.57 (12.20) 30.69 
AZTRAzitra Inc 0.00 0 per month 0.00 (0.12) 7.14 (11.36) 34.09 
SLXNBiomotion Sciences Ordinary 0.00 0 per month 0.00 (0.11) 15.09 (8.19) 37.24 
SCNIScinai Immunotherapeutics 0.00 0 per month 0.00 (0.04) 11.65 (9.29) 38.82 
SLRXSalarius Pharmaceuticals 0.00 0 per month 0.00 (0.20) 17.35 (18.03) 52.30 
HEPAHepion Pharmaceuticals 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 

Enveric Biosciences Additional Predictive Modules

Most predictive techniques to examine Enveric price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Enveric using various technical indicators. When you analyze Enveric charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Enveric Biosciences Predictive Indicators

The successful prediction of Enveric Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Enveric Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Enveric Biosciences based on analysis of Enveric Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Enveric Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Enveric Biosciences's related companies.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Complementary Tools for Enveric Stock analysis

When running Enveric Biosciences' price analysis, check to measure Enveric Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enveric Biosciences is operating at the current time. Most of Enveric Biosciences' value examination focuses on studying past and present price action to predict the probability of Enveric Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enveric Biosciences' price. Additionally, you may evaluate how the addition of Enveric Biosciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Global Correlations
Find global opportunities by holding instruments from different markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance